Introduction
============

Chronic obstructive pulmonary disease (COPD) is defined as a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by an airflow limitation that is not fully reversible. The airflow limitation is usually progressive, and associated with an abnormal inflammatory response of the lung to noxious particles or gases ([@b4-copd-3-423]; [@b7-copd-3-423]). This disease has a significant impact on the quality of life for patients and their families, and kills millions of people worldwide ([@b4-copd-3-423]; [@b22-copd-3-423]; [@b7-copd-3-423]). In 2004, the American Thoracic Society/European Respiratory Society guidelines introduced into its definition the concept that, although COPD affects the lungs, it also produces significant systemic consequences ([@b4-copd-3-423]).

Patients with significant COPD have respiratory and peripheral muscle weakness ([@b8-copd-3-423]). Respiratory muscle weakness may contribute to dyspnea and to poor exercise performance ([@b17-copd-3-423]; [@b19-copd-3-423]), and for this reason, those patients must breathe at high lung volumes to maintain patency of their narrowed airways. The major abnormality of respiratory muscle function in these patients is thought to be the mechanical disadvantage caused by the hyperinflation, which depresses the dome of the diaphragm, shortens its fibers, and forces it to work on an ineffective portion of its length/tension curve.

In other words, both the loss of the lung's elastic recoil, and the development of expiratory flow limitations promote progressive air trapping, with an increase in the end-expiratory lung volume and a decrease in inspiratory capacity (IC). Hence, this static lung hyperinflation, and its increase during exercise (dynamic hyperinflation), have been associated with limitations in the functional capacity of those patients ([@b5-copd-3-423]; [@b13-copd-3-423]). Therefore, we believed ventilatory muscle training in these patients could be beneficial in enhancing respiratory muscle function and potentially reducing the severity of breathlessness, leading to improved exercise tolerance.

The present study was performed in order to investigate the effect of a short term program of IMT (inspiratory muscle training) on inspiratory muscle performance, the perception of dyspnea, and also its effect on the prognostic index (inspiratory fraction) in patients with significant COPD. We worked with the inspiratory fraction (the ratio of IC to total lung capacity \[TLC\]), which is a noninvasive test that can be easily measured in a lung function laboratory ([@b16-copd-3-423]). This fraction reflects not only the degree of lung hyperinflation, but also the functional reserve in patients with COPD ([@b3-copd-3-423]).

Patients and methods
====================

Subjects
--------

Our study consisted of 30 patients (24 males and 6 females) of moderate and severe COPD, with spirometric evidence of significant chronic air-flow limitation (forced expiratory volume in one second (FEV~1~) \<50% predicted, FEV~1~/forced vital capacity \[FVC\] \<70% predicted), who were diagnosed as having COPD according to the criteria of the [@b1-copd-3-423], and were recruited from an outpatient clinic for the study. Thirty eight patients were invited to participate in the study, but only thirty patients had agreed to participate, and of those subjects, 3 patients were eventually excluded.

Subjects were observed during a 4-week run-in period, with their regular treatment maintained to verify stability in their clinical and functional status. This relatively stable state means that our patients were out of exacerbation of COPD or hospitalization for this period. Their characteristics are summarized in [Table 1](#t1-copd-3-423){ref-type="table"}. Patients with cardiac disease or poor compliance were excluded from the study; 3 potential patients were excluded out of the study due to their cardiac problems.

Study design
------------

All tests were performed before the training and within 1 week after its completion. After this, 27 subjects were assigned to receive specific inspiratory muscle training (SIMT). The program consists of two simultaneous parts: IMT at home for a period of 30 min/day for six days a week, and an outpatient rehabilitation program with three times weekly education and bicycle training. In this second part, patients underwent 30 minutes of exercise and education and a 30 minute session of cycling on an ergometric bicycle.

With all patients, we performed several practice tests before obtaining the baseline value in order to correct possible training and learning effects. All data were collected by the same investigator, who was blinded to the patients and to the mode of treatment. The study protocol was approved by the institutional ethics committee, and informed consent was obtained from all the participants.

Tests
-----

### Spirometry

The FVC, FEV~1~, IC and TLC were measured three times on a computerized spirometer (MS MediSoft Module 5500; USA) and the results of the best trial are reported.

The IC was measured according to the protocol described by [@b14-copd-3-423], and we used the ratio (IC/TLC: Inspiratory Fraction) as a measure of resting hyperinflation.

### 6 minute walk test (6 MWT)

The distance that the patient was able to walk in 6 min was determined in a measured corridor, as described for the 12-min walk test by [@b12-copd-3-423]. The patients were instructed to walk at their fastest speed and to cover the longest possible distance over 6 min under the supervision of a physiotherapist. The test was performed twice, and the best result is reported.

### Inspiratory muscle strength

Inspiratory muscle strength was assessed by measuring the maximal inspiratory pressure (PI max) at residual volume and total lung capacity, respectively, as previously described by [@b2-copd-3-423]. The value obtained from the best of at least three efforts was used. IMT was performed using a threshold muscle trainer (Threshold Inspiratory Muscle Trainer, Health-Scan; USA).

### Dyspnea

Dyspnea was assessed using a modified Borg scale ([@b6-copd-3-423]), which is a scale of numbers ranking the magnitude of difficulty in breathing ranging from 0 (non) to 10 (maximal). Measurement of dyspnea was taken place daily at the end of 30 minutes of IMT.

### Training protocol

Subjects trained daily, six times a week, with each session consisting of 30 minutes. There were no fixed number of repetitions of training for all patients, but they were requested to achieve as much training as possible during each session of IMT. Training lasted for three months, and was performed using a threshold inspiratory trainer. The subjects started breathing at a resistance equal to 15% of their PI max for three days. The resistance was then increased incrementally by 10% each two days, to reach 60% of their PI max at the end of the first two weeks of training. SIMT was then continued at 60% of the PI max until the end of the training period.

### Data analysis

The results are expressed as the mean ± standard deviation (SD). Comparisons of lung function, respiratory muscle strength and endurance, the results of the 6 MWT, and the rating of dyspnea within the group was carried out using the two-way repeated-measures analysis of variance.

Results
=======

All values are expressed as mean ± SD unless stated otherwise. [Table 1](#t1-copd-3-423){ref-type="table"} shows the relevant anthropometric and lung function characteristics of the 27 COPD patients. There were no significant differences between the patients for age, body mass index (BMI), mean FEV~1~, and FVC, PI max, dyspnea, IF, and the 6 MWT at the beginning of the study; in other words, all patients initially had approximately the same scores for these parameters.

Spirometry
----------

Following the IMT period, there was no significant change in the FEV~1~ or in the FVC in the group of patients as shown in [Table 2](#t2-copd-3-423){ref-type="table"}.

Inspiratory muscle strength
---------------------------

Following the training period there was a statistically significant increase in the PI max in most of our patients, from 40 cm ± 3.6 cm to 54 cm ± 3.9 cm H^2^o; *p* \< 0.005. There was also a statistically significant increase in the PI max predicted values, from 59% ± 19.1% to 79 ± 21.85%; *p* = 0.0342 ([Table 2](#t2-copd-3-423){ref-type="table"}).

6WMT
----

There was a statistically significant improvement in the distance walked during the 6 MWT following the training period in most of the patients, from 245.90 m ± 52.37 m to 302.4 m ± 41.30 m; *p* = 0.0054). This increase of 57 m in the mean distance walked in 6 minutes is shown in [Table 2](#t2-copd-3-423){ref-type="table"}.

Dyspnea
-------

A statistically significant decrease in the mean Borg score of dyspnea during breathing against resistance was associated with an increase in inspiratory muscle strength in the group of patients (5.8 ± 0.78 to 1.9 ± 0.57; *p* = 0.0001) ([Table 2](#t2-copd-3-423){ref-type="table"}).

Inspiratory fraction
--------------------

An increase, but not statistically significant, in the ratio IF = IC/TLC was noted following the inspiratory training period (from 27.6% ± 9.7% to 31.4% ± 9.8%; *p* = 0.4) ([Table 2](#t2-copd-3-423){ref-type="table"}).

Discussion
==========

To our knowledge, this is the first study to use the ratio IC/TLC (IF), which is an independent predictor of all-cause and respiratory mortality in patients with COPD, in order to evaluate the outcome of an outpatient IMT in those patients.

This study shows that in patients with significant COPD, inspiratory muscles can be trained with improvement of muscle strength, as measured by the increasing of PI max. The improvement in the inspiratory muscle performance is associated with improved exercise performance and in the sensation of dyspnea in daily activities, with no improvement in FEV~1~ or FVC.

Respiratory muscles in COPD have considerably different loading patterns than other skeletal muscles. In limb muscles, especially lower-extremity muscles, muscle weakness and respiratory insufficiency lead to inactivity and chronic underloading of the muscles. In contrast, respiratory muscles have to deal with an increased workload to breathe, and are thus chronically overloaded ([@b10-copd-3-423]). These muscles are also compromised by hyperinflation, produced by airway collapse and low elastic recoil ([@b20-copd-3-423]; [@b15-copd-3-423]).

The scientific evidence about IMT at the present time is somewhat controversial. However, in a meta-analysis of 17 articles on SIMT ([@b21-copd-3-423]), it has been shown that when the training stimulus was adequate to induce a significant improvement in respiratory muscle performance there was a significant reduction in the severity of dyspnea and an improved functional exercise capacity.

In the present study, it has been demonstrated that the improvement in the inspiratory muscle performance was associated with an increase in the 6 MWT distance and in the sensation of dyspnea during breathing against resistance. Although this increase may possibly be influenced by the accompanying outpatient program, but our results were obtained after the end of our IMT program, and we did not wait until the end of the accompanying program. Such results parallel other studies, in which significantly increased inspiratory muscle performance was associated with improved exercise tolerance and decreased dyspnea ([@b9-copd-3-423]).

The perception of dyspnea is critical, but it presents a paradox to patients with airway obstruction. It limits daily activity and impairs quality of life and provides a warning of deterioration.

It has been shown that there is a close relationship between the sensation of breathlessness and respiratory muscle force both in healthy subjects and in patients with COPD who have severe lung function impairment ([@b18-copd-3-423]). The respiratory muscles, like other skeletal muscles, can be trained ([@b17-copd-3-423]), resulting in a significant improvement in respiratory muscle performance. This increase in respiratory muscle performance was associated with a decrease in the sensation of breathlessness in patients who had COPD with a pretraining respiratory muscle weakness ([@b18-copd-3-423]).

We utilized the IF, which reflects not only the degree of lung hyperinflation but also the functional reserve in patients with COPD ([@b3-copd-3-423]). Indeed, it is a noninvasive test that can be easily measured in a lung function laboratory ([@b16-copd-3-423]; [@b11-copd-3-423]). It provides a descriptor of the severity of lung impairment and is thus an independent and excellent predictor of respiratory-related and other mortalities in COPD. The 25% IC/TLC value offers the best combined sensitivity, specificity, positive and negative predictive value ([@b3-copd-3-423]). The use of this index in our study with its improvement (from 27% to 31%) affords a good idea of the positive effect of our IMT in the life of COPD patients.

Therefore, our present study contributes additional information to the knowledge regarding the benefits of IMT on exercise capacity and dyspnea in daily activities. It supports previous data that an outpatient program can provide benefits to patients with COPD.

A second important outcome of the current study, although comparison with an inpatient program was not made, is that IMT in patients with significant COPD may be performed at home, under some supervision, with relatively good compliance.

The third important finding of the current study is the use of the IF for evaluating the outcome of the program which measured the resting hyperinflation in patients with COPD and predicted the mortality of all causes in these groups of patients.

However, this study had some limitations. First, there was no control group. This was because the study was not designed to compare the outcome of an outpatient with an inpatient program, or to compare inspiratory with expiratory muscle training. Secondly, few women were included. This low number probably reflects the problem of underdiagnosis of COPD in women, and possibly the relatively late beginning of smoking among women. Third, we would have liked to follow our patients for a longer period. Fourth, the size of our population was relatively small, which affected the significance of our results.

Finally, the current study was not designed to determine whether domiciliary IMT reduces exacerbations and hospital admissions in COPD patients. Further studies should be performed in order to overcome these problems and limitations.
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###### 

Anthropometric, pulmonary, and respiratory muscle data at baseline of 30 COPD patients

                          Study entry       Beginning of IMT[\*](#tfn1-copd-3-423){ref-type="table-fn"}
  ----------------------- ----------------- -------------------------------------------------------------
  Subjects *n*            30                27
  Age yr                  61 ± 8.87 yrs     61 ± 8.87 yrs
  Sex M/F                 24/6              21/6
  Smoking/nonsmoking      26/4              23/4
  BMI kg, m^2^            24 ± 0.9          24 ± 0.9
  FEV~1~% predicted       33.8% ± 7.69%     33.6% ± 8.04%
  FVC% predicted          73.6% ± 14.3%     72.7% ± 17.7%
  FEV~1~/FVC% predicted   45.92% ± 7.1%     46.21% ± 6.7%
  TLC% predicted          115.8% +/− 4.6%   116% +/− 3%
  IF% predicted           32.1% ± 4.3%      32.02% +/− 5.1%
  PI max% predicted       59.2% +/−17.3%    59% ± 19.1%

**Notes:** There was a period of four weeks of run-in between the study entry and the beginning of IMT.

**Abbreviations:** BMI, body mass index; IMT, inspiratory muscle training; COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in the first second; FEV~1~/FVC, Tiffeneau index; FVC, forced vital capacity; PI max, maximal inspiratory pressure; IF, inspiratory fraction.

###### 

Values[\*](#tfn3-copd-3-423){ref-type="table-fn"} at baseline and following training for pulmonary function, muscle data, IF, dyspnea, and distance of 6 MWT

                          Baseline        After SIMT      *p* value
  ----------------------- --------------- --------------- --------------------------------------------------
  FEV~1~% predicted       33.6 ± 8.04     33.9 ± 9.6      0.849
  FVC% predicted          72.7 ± 17.7     71.80 ± 18.27   0.93
  FEV~1~/FVC% predicted   46.21 ± 6.7     47.2 ± 5.6      0.87
  IF% predicted           27.6 ± 9.7      31.4 ± 9.8      0.40
  PI max% predicted       59 ± 19.10      79 ± 21.85      0.0342[†](#tfn4-copd-3-423){ref-type="table-fn"}
  Dyspnea                 5.8 ± 0.78      1.9 ± 0.567     0.0001[†](#tfn4-copd-3-423){ref-type="table-fn"}
  6 MWT                   245.9 ± 52.37   302.4 ± 41.3    0.0054[†](#tfn4-copd-3-423){ref-type="table-fn"}

**Notes:** Values are expressed as mean ± SD.

Statistically significant.

**Abbreviations:** 6 MWT, 6 minute walk test; SD, standard deviation; SIMT, specified inspiratory muscle training.
